Access Bio, Inc. (KOSDAQ:950130)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,415.00
-70.00 (-2.01%)
Apr 30, 2026, 3:30 PM KST

Revenue by Segment

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Manufacturing and Selling in Vitro Diagnostic Kits
348.64B1.03T505.11B121.80B43.06B
Manufacturing and Selling in Vitro Diagnostic Kits Growth
-66.28%104.68%314.71%182.86%7.01%
Total
348.64B1.03T505.11B121.80B43.06B
Total Growth
-66.28%104.68%314.71%182.86%7.01%

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Africa
1.22B758.78M6.70B12.45B27.93B
Africa Growth
61.13%-88.68%-46.18%-55.42%-6.76%
Oceania
4.93M162.12B40.57B826.38M1.10B
Oceania Growth
-100.00%299.59%4809.64%-25.01%50.91%
America
331.35B813.03B446.54B79.37B749.25M
America Growth
-59.24%82.07%462.64%10492.76%-68.14%
Europe
37.25M107.31M1.51B1.40B3.60B
Europe Growth
-65.28%-92.89%7.56%-61.04%7.23%
Asia
13.72B30.37B30.41B18.28B9.27B
Asia Growth
-54.83%-0.16%66.40%97.24%114.53%
Total
346.33B1.01T525.74B112.32B42.65B
Total Growth
-65.59%91.42%368.06%163.39%4.75%
Source: S&P Global Market Intelligence.